XEN-101 (Xenexus Pharmaceuticals)

N/A

Report date: 2025/01/26 17:14:39
NME

Base Information

Drug NameXEN-101 (Xenexus Pharmaceuticals)
Drug Alias Namerepurposed small molecule therapeutics (Xenexus Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXenexus Pharmaceuticals Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXenexus Pharmaceuticals Pty Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A